中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2009, Vol. 44 Issue (14) :1041-1043    DOI:
���� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
���ܶ�֬������Ϊҩ��������о���չ��Ӧ��ǰ��
���²�;�±���
�й�ҽѧ��ѧԺ����ҽѧ�о���,����Э��ҽѧԺ����ѧԺ,����ҽѧ��������ѧ�ص�ʵ���� ���� 100005

Download: PDF (0KB)   HTML (0KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ���������ܶ�֬������Ϊҩ��������о���չ��Ӧ��ǰ���������Խ��������о�����Ϊ����,���ݸ��ܶ�֬���׵Ľṹ�ʹ�л;��,�Ը��ܶ�֬������Ϊҩ����������ԡ�Ӧ���о��Ƚ���������������ܶ�֬�����������������С���ܶ���ߵ�֬����,���ж��ص���ˮ��-��ˮ�Խṹ����Դ�Կ���ȫ�����Լ�������״��Ƥϵͳʶ�������ȶ�����Ϊҩ����������ԡ��Ը��ܶ�֬����Ϊҩ������,�����ܹ�������״��Ƥϵͳ�����,�˷�ҩ��ˮ���Ժ������Բ��������ǿ��ȱ��,���ҿ���ͨ������鵼�Ļ���ѡ���������ض���λ��ҩ��Ũ��,��ǿҩ��Ļ��ԡ����۸��ܶ�֬������Ϊһ��DZ�ڵĸ�Ч������ҩ�������ܵ�Խ��Խ�������,���о޴�ķ�չDZ����Ӧ��ǰ����
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
�ؼ����� ���ܶ�֬����   ҩ������   ��������     
Abstract��
Keywords��   
�ո�����: 2008-12-10;
��������:�����ص�����о���973����Ŀ����(2006CB503801)
���ñ���:   
.���ܶ�֬������Ϊҩ��������о���չ��Ӧ��ǰ��[J]  �й�ҩѧ��־, 2009,V44(14): 1041-1043
.[J]  Chinese Pharmaceutical Journal, 2009,V44(14): 1041-1043
��
[1] JANKNEGT R. Liposomal formulations of cytotoxic drugs[J]. Support Care Cancer��1996��4��4��:298-304.
[2] KHAZAELI M B��CONRY R M��LOBUGLIO A F. Human immune response to monoclonal antibodies[J]. J Immunother Emphasis Tumor Immunol��1994��15��1����42-52.
[3] COUNSELL R E��POHLAND R C. Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents[J]. J Med Chem��1982��25��10����1115-1120.
[4] NIKANJAM M��GIBBS A R��HUNT C A��et al. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme[J]. J Controlled Release��2007��124��3����163-171.
[5] MASQUELIER M��VITOLS S��P?LSSON M��et al. Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy�� study of stability of drug-carrier complexes in blood[J]. J Drug Target��2000��8��3����155-164.
[6] KADER A��PATER A. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells[J]. J Controlled Release��2002��80��1-3����29-44.
[7] BIJSTERBOSCH M K��SCHOUTEN D��VAN BERKEL T J. Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles[J]. Biochemistry��1994��33��47����14073-14080.
[8] YAN Y J��LI Y��LOU B��et al. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice[J]. Life Sci��2006��79��2����210-215.
[9] MCDONALD M C��DHADLY P��COCKERILL G W��et al. Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock[J]. Shock��2003��20��6����551-557.
[10] NICHOLLS S J��CUTRI B��WORTHLEY S G��et al. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits[J]. Arterioscler Thromb Vasc Biol��2005��25��11����2416-2421.
[11] NICHOLLS S J��TUZCU E M��SIPAHI I��et al. Relationship Between Atheroma Regression and Change in Lumen Size After Infusion of Apolipoprotein A-I Milano[J] J Am Coll Cardiol��2006��47��5����992�C997.
[12] WASAN K M��BROCKS D R��LEE S D��et al. Impact of lipoproteins
[13] on the biological activity and disposition of hydrophobic drugs��implications for drug discovery[J]. Nat Rev Drug Discov��2008��7��1����84-99.
[14] HAUSENLOY D J��YELLON D M. Targeting residual cardiovascular risk��raising high-density lipoprotein cholesterol levels[J]. Heart��2008��94��6����706-714.
[15] FAZIO S��LINTON M F. Apolipoprotein AI as therapy for atherosclerosis�� does the future of preventive cardiology include weekly injections of the HDL protein?[J]. Mol Interv��2003��3��8����436-440.
[16] RENSEN P C��DE VRUEH R L��KUIPER J��et al. Recombinant lipoproteins�� lipoprotein-like lipid particles for drug targeting[J]. Adv Drug Deliv Rev��2001��47��2-3����251-276.
[17] PATERN�� R��RUOCCO A��POSTIGLIONE A��et al. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke[J]. Cerebrovasc Dis��2004��17��2-3����204-211.
[18] HAMIDI M��FOROOZESH M��ZARRIN A. Lipoproteins�� from physiological roles to drug delivery potentials[J]. Crit Rev Ther Drug Carrier Syst��2006��23��6����497-523.
[19] LACKO A G��NAIR M��PARANJAPE S��et al. High density lipoprotein complexes as delivery vehicles for anticancer drugs[J]. Anticancer Res��2002��22��4����2045-2049.
[20] MCCONATHY W J��NAIR M P��PARANJAPE S��et al. Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel[J]. Anti Cancer Drugs��2008��19��2����183-188.
[21] LOU B��LIAO X L��WU M P��et al. High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells[J]. World J Gastroenterol��2005��11��7����954-959.
[22] FENG M��CAI Q��HUANG H��et al. Liver targeting and anti-HBV activity of reconstituted HDL-acyclovir palmitate complex[J]. Eur J Pharm Biopharm��2008��68��3����688-693.
[23] FENG M��CAI Q��SHI X��et al. Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells[J]. J Drug Target��2008��16��6����502-508.
[24] ODA M N��HARGREAVES P L��BECKSTEAD J A��et al. Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B[J]. J Lipid Res��2006��47��2����260-267.
[25] FRIAS J C��MA Y��WILLIAMS K J��et al. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging[J]. Nano Lett��2006��6��10����2220-2224.
[26] FRIAS J C��WILLIAMS K J��FISHER E A��et al. Recombinant HDL-like nanoparticles�� a specific contrast agent for MRI of atherosclerotic plaques[J]. J Am Chem Soc��2004��126��50����16316-16317.
[27] SCHERR M��BATTMER K��DALLMANN I��et al. Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation model[J]. Oligonucleotides��2003��13��5����353-363.
[28] SONG E��LEE S K��WANG J��et al. RNA interference targeting Fas protects mice from fulminant hepatitis[J]. Nat Med��2003��9��3����347-351.
[29] WOLFRUM C��SHI S��JAYAPRAKASH K N��et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs[J]. Nat Biotechnol��2007��25��10����1149-1157.
[30] KIM S I��SHIN D��CHOI T H��et al. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I[J]. Mol Ther��2007��15��6����1145-1152.
[31] BIJSTERBOSCH M K��VAN BERKEL T J. Lactosylated high density lipoprotein�� a potential carrier for the site-specific delivery of drugs to parenchymal liver cells[J]. Mol Pharmacol��1992��41��2����404-411.
[1] ½���� ׯ�꾲 ���.���׽��ҩ���о���չ[J]. �й�ҩѧ��־, 2012,47(7): 481-485
[2] ���ٻ� ����� ����̩ ���� Ԭ�� ���� ������ ���� �ƺ��� ���� ����.ŵ���������Ʊ�Ƥ��������-2�����������ת�������ٰ����ٴ�ʵ��[J]. �й�ҩѧ��־, 2011,46(24): 1956-1958
[3] ����ǫ ������ ���� ������.֬�����Ʊ����������о���չ[J]. �й�ҩѧ��־, 2011,46(14): 1084-1088
[4] �˲� ����Ⱥ ����.��������ҩ��༤ø���Ƽ����µ�����Ƥ����Ӧ�о���չ[J]. �й�ҩѧ��־, 2010,45(23): 1793-1795
[5] ����;÷��;Ҷ��;����ǿ.�������ᡪ���׸���׼���еĶ�е��������ҩ��[J]. �й�ҩѧ��־, 2008,43(18): 1438-1440
[6] Ԭ־��;����;��־��;�ﳤ��.ˮ���ԿǾ���-�������������ĺϳ������[J]. �й�ҩѧ��־, 2007,42(19): 1449-1451
[7] ������ ;�½�Ӣ;����;¦����.����͸�������������Ʊ���ˮ����Ĥ����ҩ���ͷ��о�[J]. �й�ҩѧ��־, 2006,41(12): 931-934
[8] ��ϣƽ;��ԪӢ.ת��������Ϊ��������������о���չ[J]. �й�ҩѧ��־, 2005,39(08): 568-571
[9] ½����������.��������ҩ��������о���չ[J]. �й�ҩѧ��־, 1996,31(02): 67-70
[10] ��̲�������.��ù��֬�����������Ӧ�ý�չ[J]. �й�ҩѧ��־, 1995,30(09): 518-521
[11] ���£�������.����ҩ�����婤�����΢��[J]. �й�ҩѧ��־, 1995,30(02): 69-71
[12] ��ѧ�����ι�����Ҧٻ.��΢����Ϊҩ�������Ӧ��[J]. �й�ҩѧ��־, 1994,29(11): 643-646
[13] ��־�٣��󹧿��ι���.����Һ��С������Ϊҩ�������Ӧ��[J]. �й�ҩѧ��־, 1993,28(01): 46-48
[14] �����ˣ�л����.�����̴���ҩ����HMGoA��ԭø���Ƽ�[J]. �й�ҩѧ��־, 1992,27(02): 111-113
[15] .�ķ�������� .����Ӣ����ѩ��.�������Ծ������֢����Ѫ����ܶ�֬���׼���������е��̴�������Ӱ��[J]. �й�ҩѧ��־, 1990,25(06): 345-348
Copyright 2010 by �й�ҩѧ��־